EID3 (EP300 interacting inhibitor of differentiation 3) functions as a transcriptional repressor that modulates cellular differentiation, DNA repair, and cancer progression through multiple mechanisms. EID3 acts as an inhibitor of CBP/p300-dependent transcription by directly binding to the SRC-1 interacting domain of CBP, blocking recruitment of coactivators to nuclear receptor-regulated promoters 1. The protein plays crucial roles in DNA damage response, with elevated EID3 levels following radiochemotherapy promoting gastric cancer stem cell biogenesis through interaction with NAMPT and activation of Wnt signaling 2. EID3 is essential for mammalian spermatogenesis, regulating meiosis and chr12 condensation during sperm development, with deficiency leading to impaired histone-to-protamine transition and abnormal sperm morphology 3. In cancer contexts, EID3 demonstrates oncogenic properties by promoting glioma cell proliferation and survival through AMPKα1 inactivation 4, and is highly expressed in colorectal cancer cells with low proteasome activity, contributing to treatment resistance 5. EID3 also regulates stem cell differentiation, directly associating with DNMT3A during transdifferentiation of mesenchymal stem cells to neural progenitor-like cells 6. These findings establish EID3 as a multifunctional protein critical for transcriptional regulation, DNA repair responses, and cellular differentiation processes.